Literature DB >> 11464952

The skin in amyotrophic lateral sclerosis.

S Ono1.   

Abstract

It has been repeatedly noted, but never as yet fully explained, that patients with ALS do not develop bedsores even at the terminal stage. Furthermore, the skin of ALS patients feels supple, like tanned leather, and loses elasticity. When the skin is stretched, it returns only sluggishly to its original position. We termed this property of skin 'delayed return phenomenon (DRP)'; it is usually seen more than 2 1/2 years after the onset of symptoms. Though it is thought that phenomena such as DRP and the absence of bedsores are characteristic of this disease, little attention has been paid to these unique features in ALS patients. In this review we summarize recent developments in research on skin from ALS patients, which may give insight into the possible mechanisms and pathogenesis underlying this disorder.

Entities:  

Mesh:

Year:  2000        PMID: 11464952     DOI: 10.1080/14660820050515188

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  11 in total

1.  Metalloproteinase alterations in the bone marrow of ALS patients.

Authors:  Patrizia Bossolasco; Lidia Cova; Cinzia Calzarossa; Federica Servida; Niccolò Emanuele Mencacci; Francesco Onida; Elio Polli; Giorgio Lambertenghi Deliliers; Vincenzo Silani
Journal:  J Mol Med (Berl)       Date:  2010-01-21       Impact factor: 4.599

Review 2.  Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Authors:  Emanuele D'Amico; Pam Factor-Litvak; Regina M Santella; Hiroshi Mitsumoto
Journal:  Free Radic Biol Med       Date:  2013-06-21       Impact factor: 7.376

3.  Emotional responding in amyotrophic lateral sclerosis.

Authors:  Dorothée Lulé; Anja Kurt; Reinhart Jürgens; Jan Kassubek; Volker Diekmann; Eduard Kraft; Nicola Neumann; Albert C Ludolph; Niels Birbaumer; Silke Anders
Journal:  J Neurol       Date:  2005-06-24       Impact factor: 4.849

4.  Oxidative stress biomarkers in sporadic ALS.

Authors:  Hiroshi Mitsumoto; Regina M Santella; Xinhua Liu; Mikhail Bogdanov; Jennifer Zipprich; Hui-Chen Wu; Julie Mahata; Mary Kilty; Kate Bednarz; Daniel Bell; Paul H Gordon; Mady Hornig; Mahsa Mehrazin; Ali Naini; M Flint Beal; Pam Factor-Litvak
Journal:  Amyotroph Lateral Scler       Date:  2008-06

Review 5.  Management of amyotrophic lateral sclerosis.

Authors:  Philippe Corcia; Vincent Meininger
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  A technique for performing electrical impedance myography in the mouse hind limb: data in normal and ALS SOD1 G93A animals.

Authors:  Jia Li; Wayne L Staats; Andrew Spieker; Minhee Sung; Seward B Rutkove
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

7.  Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells.

Authors:  Giovanni Nardo; Silvia Pozzi; Mauro Pignataro; Eliana Lauranzano; Giorgia Spano; Silvia Garbelli; Stefania Mantovani; Kalliopi Marinou; Laura Papetti; Marta Monteforte; Valter Torri; Luca Paris; Gianfranco Bazzoni; Christian Lunetta; Massimo Corbo; Gabriele Mora; Caterina Bendotti; Valentina Bonetto
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

Review 8.  Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Robert Bowser; Lucie Bruijn; Luc Dupuis; Albert Ludolph; Michael McGrath; Giovanni Manfredi; Nicholas Maragakis; Robert G Miller; Seth L Pullman; Seward B Rutkove; Pamela J Shaw; Jeremy Shefner; Kenneth H Fischbeck
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

Review 9.  Amyotrophic lateral sclerosis: applications of stem cells - an update.

Authors:  Lidia Cova; Vincenzo Silani
Journal:  Stem Cells Cloning       Date:  2010-10-27

10.  TDP-43 Cytoplasmic Translocation in the Skin Fibroblasts of ALS Patients.

Authors:  Miguel A Rubio; Mireia Herrando-Grabulosa; Roser Velasco; Israel Blasco; Monica Povedano; Xavier Navarro
Journal:  Cells       Date:  2022-01-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.